The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.

Ihbe-Heffinger, A; Ehlken, B; Bernard, R; Berger, K; Peschel, C; Eichler, H-G; Deuson, R; Thödtmann, J; Lordick, F

Ihbe-Heffinger, A; Ehlken, B; Bernard, R; Berger, K; Peschel, C; Eichler, H-G; Deuson, R; Thödtmann, J; Lordick, F.

Affiliation

Ihbe-Heffinger A; Department of Pharmacy, Klinikum rechts der Isar, Technische Universität München, Germany. Angela.Ihbe-Heffinger@lrz.tu-muenchen.de

Ann Oncol ; 15(3): 526-36, 2004 Mar.

Article in En | MEDLINE | ID: mdl-14998860

Subject(s)

Antiemetics/economics; Antineoplastic Agents/adverse effects; Health Care Costs; Health Resources/statistics & numerical data; Nausea/economics; Neoplasms/drug therapy; Vomiting/economics; Antiemetics/therapeutic use; Cancer Care Facilities; Cost of Illness; Cross-Sectional Studies; Drug Costs; Female; Germany; Humans; Male; Middle Aged; Nausea/chemically induced; Nausea/drug therapy; Prospective Studies; Vomiting/chemically induced; Vomiting/drug therapy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Health Care Costs / Health Resources / Antiemetics / Nausea / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2004 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links